Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating and Characterizing the Immune Response to Prostate Cancer

NCT03331367 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03331367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03331367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating and Characterizing the Immune Response to Prostate Cancer
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
September 14, 2017
Completion date
February 25, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer